Humana (HUM) vs Oscar Health (OSCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Oscar Health (OSCR) has outperformed Humana (HUM) over the past year, gaining 47.6% versus a gain of 37.9%. Over five years, OSCR leads with a +109.3% price change compared with -7.7% for HUM. Humana is the larger company by market cap ($47.61 billion vs $10.16 billion), about 4.7 times the size, while Oscar Health is growing revenue faster (+27.5% vs +10.1%).
On valuation, Oscar Health trades at a lower forward P/E (15.2x vs 23.9x for Humana). Humana pays a dividend yielding 0.89%, while Oscar Health does not currently pay one. Humana converts more of its revenue into profit, with a net margin of 0.9% versus -3.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HUM | OSCR |
|---|---|---|
| Share price | $396.51 | $32.91 |
| Market cap | $47.61B | $10.16B |
| 1-day change | -1.92% | +1.76% |
| YTD return | +58.91% | +130.83% |
| 1-year return | +37.86% | +47.62% |
| 5-year return | -7.71% | +109.27% |
| P/E ratio (TTM) | 37.48 | 25.51 |
| Forward P/E | 23.90 | 15.20 |
| EPS (TTM) | $10.58 | $1.29 |
| Dividend yield | 0.89% | 0.00% |
| Annual dividend | $3.54 | $0.00 |
| Revenue (latest FY) | $129.66B | $11.70B |
| Revenue growth (YoY) | +10.11% | +27.50% |
| Net income (latest FY) | $1.19B | $-443.15M |
| Operating margin | 2.09% | -3.39% |
| Net margin | 0.92% | -3.79% |
| 52-week high | $428.88 | $34.48 |
| 52-week low | $163.11 | $10.69 |
| Distance from 52-week high | -7.55% | -4.55% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +6.87% | +7.57% |
| Average volume | 1.23M | 5.16M |
| Shares outstanding | 120.08M | 273.47M |
| Employees | 67,060 | 2,305 |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Plans | Healthcare Plans |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Humana is about 4.7 times larger than Oscar Health by market value ($47.61B vs $10.16B).
- Humana trades at a higher earnings multiple (37.5x vs 25.5x trailing P/E).
- Oscar Health grew revenue faster in its latest fiscal year (+27.50% vs +10.11%).
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Healthcare · Healthcare Plans · 67,060 employees
About Oscar Health
OSCR stock →Oscar Health, Inc. operates as a healthcare technology company in the United States.
Healthcare · Healthcare Plans · 2,305 employees
HUM vs OSCR FAQ
Which is bigger, Humana or Oscar Health?
Humana (HUM) is larger, with a market capitalization of $47.61B compared with $10.16B for Oscar Health (OSCR).
Which stock has performed better over the past year, HUM or OSCR?
OSCR returned +47.62% over the past 12 months, compared with +37.86% for HUM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HUM or OSCR?
OSCR has the lower trailing P/E at 25.5, versus 37.5 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Humana or Oscar Health?
Humana pays a dividend yielding 0.89%, while Oscar Health does not currently pay a regular dividend.
Are Humana and Oscar Health in the same industry?
Yes. Both are classified in the Healthcare Plans industry within the Healthcare sector.